Reaction

Angioneurotic Oedema reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,667 reports · 37 co-occurring drugs

As of the last recalculation, Angioneurotic Oedema appears in 2,667 FAERS reports alongside 37 co-occurring drug terms. The strongest observed disproportionality signal is AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE (PRR 60.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Amlodipine Besylate And Benazepril Hydrochloride	70	60.7	61.2
Enalapril Maleate	74	23.9	24.0
Felodipine Extended-Release Tablets	22	15.2	15.2
Felodipine	22	15.2	15.2
Gemfibrozil	26	13.5	13.5
Lisinopril	413	12.3	12.3
Captopril	15	12.2	12.3
Salmeterol Xinafoate	12	10.9	10.9
Enalapril	73	10.5	10.5
Lisinopril And Hydrochlorothiazide	13	10.0	10.0
Pegaspargase	13	8.3	8.3
Lisinopril And Hydrochlorothiazide Tablets	8	8.0	8.0
Amoxicillin And Clavulanate Potassium	27	7.8	7.8
Diphenhydramine Hcl	11	7.7	7.7
Valsartan And Hydrochlorothiazide	12	6.9	6.9
Diltiazem Hydrochloride Extended-Release Tablets	10	6.9	6.9
Cetirizine Hcl	8	6.8	6.8
Desloratadine	9	6.6	6.6
Irbesartan	34	6.0	6.0
Quinapril Hydrochloride	6	5.9	6.0
Atenolol	97	5.9	5.9
Glyburide	18	5.8	5.8
Extended Phenytoin Sodium	12	5.6	5.6
Valsartan	73	5.5	5.5
Gentamicin Sulfate	11	5.5	5.5
Losartan Potassium And Hydrochlorothiazide	8	5.4	5.4
Gentamicin	9	5.4	5.4
Metformin Hcl	35	5.0	5.0
Estrogens, Conjugated	37	4.9	4.9
Timolol Maleate	6	4.7	4.7
Ezetimibe And Simvastatin	9	4.6	4.6
Conjugated Estrogens	33	4.5	4.5
Pseudoephedrine Hcl	6	4.3	4.3
Agalsidase Beta	4	3.4	3.4
Sevoflurane	3	2.8	2.8
Minoxidil Foam 5% (Womens)	8	1.9	1.9
Minoxidil	8	1.4	1.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.